Profit saw 4% hike in 2024, Prodia unveils strategy for this year
14 Mar 2025 16:07
Prodia's (PRDA) revenue rose by only 1.3%, while profit grew by 4%. What's its strategy for 2025?
PRDA optimistic about 2024 dividend increase
19 Feb 2025 10:12
Weak performance, PRDA remains optimistic for dividend allocation. Here's what the CEO has to say.
PRDA to take subsidiary public
19 Feb 2025 08:41
Prodia readies its subsidiary, Proline, to debut on the stock market in the next 2-3 years.
Prodia's net profit corrected 17.5% at the end of September 2024
01 Nov 2024 14:58
PT Prodia Widyahusada Tbk (PRDA), the company that oversees the Prodia laboratory network, is still experiencing a downward trend in net profit until September 2024.
Securing medical device supply chain, Prodia spends IDR 72 billion on 39% of Proline
28 Jun 2024 12:51
PT Prodia Widyahusada Tbk (PRDA) takes an extra measure to secure supply chain of in vitro diagnostic (IVD) test tools by acquiring 39% of its affiliate, PT Prodia Diagnostic Line (Proline).
Prodia Diagnostic Line hosts topping-off for new production facility, targeting TKDN above 60%
25 Jun 2024 15:07
PT Prodia Diagnostic Line (Proline), "sister company" of PT Prodia Widyahusada Tbk (PRDA) which is engaged in manufacturing reagents and test equipment, has just held the topping off of its newest production facility building today (25/6) in the Jababeka area, Cikarang.
Hesitating on IKN, Prodia allocates 55% of capex to IT
18 Apr 2024 16:06
PT Prodia Widyahusada Tbk (PRDA) has prepared moderate amount of capital expenditure (capex) in 2024, worth a maximum of IDR 250 billion.
Profit pressured by normalisation, Prodia still set up dividend of IDR 155.6 billion
18 Apr 2024 11:14
PT Prodia Widyahusada Tbk (PRDA), a company managing Prodia laboratory network, has allocated IDR 155.6 billion to be distributed to its shareholders as cash dividend.